Bora Pharmaceuticals
Bora Pharmaceuticals Co Ltd is a Taiwanese contract development and manufacturing organization (CDMO) and pharmaceutical enterprise headquartered in Taipei, Taiwan. The company specializes in the development, clinical manufacturing, and commercial wholesale production of oral solid doses, liquids, semisolids, and complex injectable pharmaceutical products for global pharmaceutical brands. Principal revenue is derived through contract manufacturing service fees, pharmaceutical production charges, and commercial product sales. Bora Pharmaceuticals is publicly listed on the Taiwan Stock Exchange.
4 of the funds FundTelligence covers report a position in Bora Pharmaceuticals.
- Legal name
- Bora Pharmaceuticals Co Ltd
- Sector
- Health Care
- Country
- Taiwan
- Funds holding it
- 4
Funds holding Bora Pharmaceuticals
- Handelsbanken Asia SMB — Handelsbanken · 0.11 % (full portfolio disclosed, August 2026)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.01 % (full portfolio disclosed, October 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.01 % (partially disclosed portfolio, June 2026)
- BlackRock iShares MSCI EM IMI Screened UCITS ETF — BlackRock · 0.01 % (full portfolio disclosed, October 2026)